Sign in for the best experience.
Everything we publish is designed to keep you up-to-date on the latest news, approaches, and ideas in chest medicine. From the most relevant research findings to the most significant clinical guidelines, these are the highly accredited resources you count on from CHEST.
Advertisement
Used throughout the world, our multidisciplinary guidelines help translate quality evidence into applicable recommendations that enrich patient care and improve health outcomes.
FEATURED GUIDELINE
Biologic Management in Severe Asthma for Adults
This guideline examines the literature related to choice of biologic agent in patients with severe asthma and consists of seven evidence-based recommendations to optimize their use.
Management of Patients With Early-Stage Non-Small Cell Lung Cancer
This CHEST guideline examines the literature on primary treatment of patients with stage I and II non-small cell lung cancer and consists of 17 evidence-based recommendations that surgeons can implement in their own practice.
Access CHEST’s full collection of guidelines, expert panel reports, and consensus statements.
Guideline topics
Airway Disorders
Chest Infections
Clinical Pulmonary
Critical Care
Interstitial Lung Disease
Interventional Pulmonary
Pulmonary Vascular
Thoracic Oncology
The CHEST® journal portfolio features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine—pulmonary, critical care, and sleep medicine—and related disciplines. With a loyal readership base, the portfolio, including the journals CHEST, CHEST® Critical Care, and CHEST® Pulmonary, is one of the most highly regarded, and up-to-date sources of clinical knowledge in the field.
Impact of Mepolizumab on Airway Remodeling and Inflammation in Severe Eosinophilic Asthma
Interleukin-5 (IL-5) is a key mediator of severe eosinophilic asthma (SEA) and also may contribute to airway remodeling. A study in the journal CHEST® explored how mepolizumab, an anti-IL-5 antibody, may modify airway remodeling in adult patients with SEA.
Impact of a COPD Bundled Payments for Care Innovation Program on Readmissions and Inpatient Care Quality
One-fifth of US patients hospitalized for acute exacerbations of COPD are readmitted within 30 days, contributing to high morbidity and costs. A study in CHEST® Pulmonary examined the effectiveness of a Medicare COPD Hospital Readmissions Reduction Program in preventing hospital readmissions and improving inpatient care quality.
See if you can answer this question based on a CHEST clinical practice guideline.
Each month, the journal CHEST Editor in Chief Peter Mazzone, MD, MPH, FCCP, adds context and commentary to important articles featured in the new issue.
OPEN ACCESS JOURNALS | Submit your research to be published in our new journals. CHEST® CRITICAL CARE » | CHEST® PULMONARY »
Whatever your specialty, CHEST has a topic collection that you’ll be interested in. Uncover insights from key opinion leaders, find CME opportunities, and discover original research articles.
Clinical advances, practice management updates, medical conference highlights—reading the CHEST Physician® publication is the easiest way to be in the know every month.
Originally aired: April 1, 2026
CHEST® journal Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key articles published in the April 2026 issue.
Hear about research into the variation in full MIST2 regimen dosing of intrapleural enzyme therapy in adults hospitalized with complicated parapneumonic effusion of empyema.
Originally aired: March 2, 2026
Hear about research into the dose-response relationship between adjunctive corticosteroids and outcomes in adult patients with non-HIV Pneumocystis jirovecii pneumonia.